DNA-Binding Anticancer Drugs: One Target, Two Actions by Bruce C. Baguley, Catherine J. Drummond, Ying Yi Chen, Graeme J. Finlay

Get full text

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines. by Euphemia Y Leung, Marjan Askarian-Amiri, Graeme J Finlay, Gordon W Rewcastle, Bruce C Baguley

Get full text

Retrotransposon hypomethylation in melanoma and expression of a placenta-specific gene. by Erin C Macaulay, Hester E Roberts, Xi Cheng, Aaron R Jeffs, Bruce C Baguley, Ian M Morison

Get full text

Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer by Dean C. Singleton, Anne-Lise Dechaume, Pamela M. Murray, William P. Katt, Bruce C. Baguley, Euphemia Y. Leung

Get full text

Relationships between signaling pathway usage and sensitivity to a pathway inhibitor: examination of trametinib responses in cultured breast cancer lines. by Euphemia Y Leung, Ji Eun Kim, Marjan Askarian-Amiri, Gordon W Rewcastle, Graeme J Finlay, Bruce C Baguley

Get full text

Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy by Wenli Zhang, Caibin Li, Ya Jin, Xinyue Liu, Zhiyu Wang, John P. Shaw, Bruce C. Baguley, Zimei Wu, Jianping Liu

Get full text

SOX2OT Long Noncoding RNA Is Regulated by the UPR in Oestrogen Receptor-Positive Breast Cancer by Carole Ferraro-Peyret, Marjan E. Askarian-Amiri, Debina Sarkar, Wayne R. Joseph, Herah Hansji, Bruce C. Baguley, Euphemia Y. Leung

Get full text

MITF and PAX3 play distinct roles in melanoma cell migration; outline of a genetic switch theory involving MITF and PAX3 in proliferative and invasive phenotypes of melanoma by Michael R Eccles, Shujie eHe, Antonio eAhn, Lynn eSlobbe, Aaron R Jeffs, Han-Seung eYoon, Bruce C Baguley

Get full text

Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK by Khanh B. Tran, Sharada Kolekar, Anower Jabed, Patrick Jaynes, Jen-Hsing Shih, Qian Wang, Jack U. Flanagan, Gordon W. Rewcastle, Bruce C. Baguley, Peter R. Shepherd

Get full text

A gene expression signature of invasive potential in metastatic melanoma cells. by Aaron R Jeffs, Amy C Glover, Lynn J Slobbe, Li Wang, Shujie He, Jody A Hazlett, Anshul Awasthi, Adele G Woolley, Elaine S Marshall, Wayne R Joseph, Cristin G Print, Bruce C Baguley, Michael R Eccles

Get full text

The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival. by Janice A Royds, Shafagh Al Nadaf, Anna K Wiles, Yu-Jen Chen, Antonio Ahn, Alisha Shaw, Sara Bowie, Frederic Lam, Bruce C Baguley, Antony W Braithwaite, Martin R MacFarlane, Noelyn A Hung, Tania L Slatter

Get full text

Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations by Euphemia Y. Leung, Euphemia Y. Leung, Marjan E. Askarian-Amiri, Marjan E. Askarian-Amiri, Dean C. Singleton, Carole Ferraro-Peyret, Carole Ferraro-Peyret, Wayne R. Joseph, Graeme J. Finlay, Graeme J. Finlay, Reuben J. Broom, Purvi M. Kakadia, Stefan K. Bohlander, Elaine Marshall, Bruce C. Baguley

Get full text

Evidence that GRIN2A mutations in melanoma correlate with decreased survival by Stacey Ann N D'mello, Jack U Flanagan, Jack U Flanagan, Taryn N Green, Euphemia Y Leung, Marjan E Askarian-Amiri, Wayne R Joseph, Michael R McCrystal, Michael R McCrystal, Richard J Isaacs, James H F Shaw, Christopher E Furneaux, Matthew J During, Matthew J During, Graeme J FInlay, Bruce C Baguley, Maggie Lucy Kalev-Zylinska, Maggie Lucy Kalev-Zylinska

Get full text